COVID-19 Vaccines and Vaccination
A section of Vaccines (ISSN 2076-393X).
Section Information
Aims
The aim of this “COVID-19 vaccines and vaccination” special issue is to provide with information on currently available and novel experimental approaches for the development of vaccines for the control of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and it associated coronavirus disease 2019 (COVID-19).
Scope
Global efforts to develop vaccines recently have resulted in 3 FDA-approved vaccines candidates with excellent safety and efficacy profiles in human clinical trials that have resulted in large-scale vaccination campaigns early in 2021.Currently, RNA-based vaccines and replication defective adenovirus-based vector have been used for the treatment of COVID-19 in humans. However, additional safe and effective vaccines are needed for the treatment of SARS-CoV-2 infection and its associated COVID-19 disease.
In this section “COVID-19 vaccines and vaccination” we will consider original research and review articles, including short reports and full-size manuscripts, covering aspects related to SARS-CoV-2 vaccine development for the treatment of COVID-19 disease. These include (but not limited to) antigen selection; subunit, inactivated, and live-attenuated vaccines; approaches to enhance innate and adaptive B- and T-cell protective responses; vaccine adjuvants; delivery methods and strategies; immunological responses to SARS-CoV-2 infection or COVID-19 disease; and animal models to assess protection efficacy against SARS-CoV-2 infection and COVID-19 disease.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- New Trends in SARS-CoV-2 Variants and Vaccines: 2nd Edition (Deadline: 30 November 2024)
- SARS-CoV-2 Infection in Women and Children (Deadline: 31 December 2024)
- COVID-19 Vaccination and Public Health: Addressing Global, Regional and Within-Country Inequalities (Deadline: 31 December 2024)
- State-of-the-Art Vaccine Research in AustralAsia (Deadline: 31 January 2025)
- SARS-CoV-2 Variants, Vaccines, and Immune Responses (Deadline: 31 January 2025)
- Immunization Strategies and Vaccine Uptake after the SARS-CoV-2 Pandemic (Deadline: 15 February 2025)
- Knowledge, Attitudes and Associated Factors Surrounding COVID-19 Vaccination (Deadline: 28 February 2025)
- Detection of SARS-CoV-2 Neutralizing Antibodies and Vaccine Development: 2nd Edition (Deadline: 31 March 2025)
- COVID Vaccines: Design, Development, and Immune Response Studies: 2nd Edition (Deadline: 30 April 2025)
- Exploring Cutaneous Autoimmune Disease Flares in the Wake of COVID-19 Infection and Vaccination (Deadline: 10 May 2025)
- T-cell Immunity and Viral Pathogenicity on Vaccine Efficacy (Deadline: 31 May 2025)
- Understanding Immune Responses to COVID-19 Vaccines (Deadline: 31 July 2025)
- Immunization of Immunosuppressed Patients (Deadline: 31 July 2025)
Topical Collections
Following topical collections within this section are currently open for submissions:
